Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Total 13F shares
-
7,670,623
-
Share change
-
-305,747
-
Total reported value
-
$68,171,000
-
Price per share
-
$8.87
-
Number of holders
-
19
-
Value change
-
-$2,738,648
-
Number of buys
-
9
-
Number of sells
-
9
Institutional Holders of LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) as of Q3 2021
As of 30 Sep 2021,
LONGBOARD PHARMACEUTICALS, INC. - Common Stock, par value $0.0001 per share (LBPH) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,670,623 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Alyeska Investment Group, L.P., TD ASSET MANAGEMENT INC, and Integral Health Asset Management, LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.